JP2023515780A5 - - Google Patents

Info

Publication number
JP2023515780A5
JP2023515780A5 JP2022548707A JP2022548707A JP2023515780A5 JP 2023515780 A5 JP2023515780 A5 JP 2023515780A5 JP 2022548707 A JP2022548707 A JP 2022548707A JP 2022548707 A JP2022548707 A JP 2022548707A JP 2023515780 A5 JP2023515780 A5 JP 2023515780A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
independently selected
pyridine
cyclopropylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022548707A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023515780A (ja
JP7711075B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/017554 external-priority patent/WO2021163254A1/en
Publication of JP2023515780A publication Critical patent/JP2023515780A/ja
Publication of JP2023515780A5 publication Critical patent/JP2023515780A5/ja
Application granted granted Critical
Publication of JP7711075B2 publication Critical patent/JP7711075B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022548707A 2020-02-12 2021-02-11 ヘテロ環状pad4阻害剤 Active JP7711075B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN202041006146 2020-02-12
IN202041006146 2020-02-12
PCT/US2021/017554 WO2021163254A1 (en) 2020-02-12 2021-02-11 Heterocyclic pad4 inhibitors

Publications (3)

Publication Number Publication Date
JP2023515780A JP2023515780A (ja) 2023-04-14
JP2023515780A5 true JP2023515780A5 (https=) 2024-02-21
JP7711075B2 JP7711075B2 (ja) 2025-07-22

Family

ID=74856949

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022548707A Active JP7711075B2 (ja) 2020-02-12 2021-02-11 ヘテロ環状pad4阻害剤

Country Status (16)

Country Link
US (1) US12473304B2 (https=)
EP (1) EP4103559B1 (https=)
JP (1) JP7711075B2 (https=)
KR (1) KR20220140795A (https=)
CN (1) CN115348961B (https=)
AR (1) AR121299A1 (https=)
AU (1) AU2021219710A1 (https=)
BR (1) BR112022015792A2 (https=)
CA (1) CA3167753A1 (https=)
CL (1) CL2022002148A1 (https=)
CO (1) CO2022011388A2 (https=)
IL (1) IL295506A (https=)
MX (1) MX2022009874A (https=)
PE (1) PE20230679A1 (https=)
TW (1) TW202140477A (https=)
WO (1) WO2021163254A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12022551513A1 (en) 2019-12-20 2023-04-24 Mirati Therapeutics Inc Sos1 inhibitors
WO2021158840A1 (en) 2020-02-06 2021-08-12 Bristol-Myers Squibb Company Macrocyclic pad4 inhibitors useful as immunosuppressant
TW202140477A (zh) 2020-02-12 2021-11-01 美商必治妥美雅史谷比公司 雜環pad4抑制劑
WO2021222353A1 (en) 2020-04-30 2021-11-04 Gilead Sciences, Inc. Macrocyclic inhibitors of peptidylarginine deiminases
TW202233174A (zh) 2020-12-22 2022-09-01 美商基利科學股份有限公司 肽基精胺酸去亞胺酶之抑制劑
WO2022140390A1 (en) 2020-12-22 2022-06-30 Gilead Sciences, Inc. Inhibitors of peptidylarginine deiminases
KR20260041867A (ko) 2023-07-21 2026-03-27 브리스톨-마이어스 스큅 컴퍼니 Pad4 조정제의 시트룰린화 및 활성을 평가하는 방법
WO2026020127A2 (en) 2024-07-19 2026-01-22 Bristol-Myers Squibb Company Methods of assessing citrullination and activity of pad2 modulators

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60007310D1 (de) 1999-06-04 2004-01-29 Elan Pharma Int Ltd Zusammensetzungen und methoden zur verhinderung des zelltods
MX2007010371A (es) 2005-02-25 2008-01-11 Tetralogic Pharmaceuticals Inhibidores dimericos iap.
US7825154B2 (en) 2005-08-12 2010-11-02 The United States Of America As Represented By The Secretary Of The Army Small molecule inhibitors of botulinum neurotoxins
CN101466670B (zh) 2006-04-07 2013-04-17 梅特希尔基因公司 组蛋白脱乙酰酶抑制剂
US7842713B2 (en) 2006-04-20 2010-11-30 Pfizer Inc Fused phenyl amido heterocyclic compounds
EP2120952A4 (en) 2007-01-15 2011-09-21 Us Of America As Represented By The Secretary Of The Army On Behalf Of The U S Army Res Inst Of Infe ANTIVIRAL COMPOUNDS AND METHODS OF USE
US20110052562A1 (en) 2007-12-19 2011-03-03 The Scripps Research Institute Benzimidazoles and analogs as rho kinase inhibitors
JP2010013386A (ja) 2008-07-02 2010-01-21 Fujifilm Corp 染毛剤、染毛方法およびその製造方法
WO2013040528A1 (en) 2011-09-16 2013-03-21 Microbiotix, Inc. Antimicrobial compounds
WO2013052263A2 (en) 2011-09-16 2013-04-11 Microbiotix, Inc. Antifungal compounds
KR101916443B1 (ko) * 2012-07-26 2018-11-08 글락소 그룹 리미티드 Pad4 억제제로서의 2-(아자인돌-2-일) 벤즈이미다졸
CN103030627B (zh) 2013-01-07 2017-11-10 中国科学院上海有机化学研究所 一种噻吩环/呋喃环‑杂芳环结构的合成方法
WO2014177593A1 (en) 2013-04-29 2014-11-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Amorfrutin analogs as ppargamma-modulators
WO2016004513A1 (en) 2014-07-11 2016-01-14 Simon Fraser University Anti-bacterial pyruvate kinase modulator compounds, compositions, uses and methods
KR101501091B1 (ko) 2014-09-04 2015-03-10 주식회사 해치엠엠에이 도포용 바닥재의 미끄럼방지 요철형성용 롤러장치
KR20180005250A (ko) * 2015-05-21 2018-01-15 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 Pad4 억제제로서의 벤조이미다졸 유도체
US20180312493A1 (en) 2015-11-04 2018-11-01 Simon Fraser University Antibiotic Compounds, Pharmaceutical Formulations Thereof And Methods And Uses Therefor
AR107032A1 (es) 2015-12-09 2018-03-14 Padlock Therapeutics Inc Inhibidores bicíclicos de pad4
AR107030A1 (es) * 2015-12-09 2018-03-14 Padlock Therapeutics Inc Inhibidores aza-bencimidazol de pad4
US10654814B2 (en) * 2015-12-22 2020-05-19 Kancera Ab Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity
CA3015482A1 (en) 2016-02-23 2017-08-31 Padlock Therapeutics, Inc. Heteroaryl inhibitors of pad4
WO2018022897A1 (en) 2016-07-27 2018-02-01 Padlock Therapeutics, Inc. Covalent inhibitors of pad4
US11026937B2 (en) 2016-09-12 2021-06-08 Padlock Therapeutics, Inc. Heteroaryl inhibitors of PAD4
JP2018140974A (ja) 2017-02-28 2018-09-13 国立大学法人 奈良先端科学技術大学院大学 放射線検出方法及び放射線検出器並びに放射線検出に用いられる新規化合物
CN108689942B (zh) 2017-04-11 2023-06-09 广东东阳光药业有限公司 含氮双环化合物及其制备方法和用途
JP7311228B2 (ja) * 2017-06-30 2023-07-19 ベイジン タイド ファーマシューティカル カンパニー リミテッド Rho-関連プロテインキナーゼ阻害剤、それを含む医薬組成物並びにその調製方法及び使用
ES2932627T3 (es) 2017-08-22 2023-01-23 Bayer Ag Derivados heterocíclicos como pesticidas
AU2018352142B2 (en) * 2017-10-18 2022-08-25 Jubilant Epipad LLC Imidazo-pyridine compounds as PAD inhibitors
MX2021001565A (es) 2018-08-08 2021-04-19 Bristol Myers Squibb Co Inhibidores tipo indol y azaindol de enzimas peptidil arginina deiminasas (pad).
MX2021001471A (es) 2018-08-08 2021-04-28 Bristol Myers Squibb Co Benzimidazoles sustituidos como inhibidores de peptidil arginina deiminasa 4 (pad4).
JP7447080B2 (ja) 2018-08-08 2024-03-11 ブリストル-マイヤーズ スクイブ カンパニー Pad4阻害剤としての置換チエノピロール
US20220348562A1 (en) 2018-08-08 2022-11-03 Bristol-Myers Squibb Company Benzimidazole inhibitors of pad enzymes
WO2021158840A1 (en) 2020-02-06 2021-08-12 Bristol-Myers Squibb Company Macrocyclic pad4 inhibitors useful as immunosuppressant
TW202140477A (zh) 2020-02-12 2021-11-01 美商必治妥美雅史谷比公司 雜環pad4抑制劑

Similar Documents

Publication Publication Date Title
JP2023515780A5 (https=)
IL295506A (en) Heterocyclic pad4 inhibitors
US11529356B2 (en) 2-(morpholin-4-yl)-1,7-naphthyridines
JP2022531801A5 (https=)
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
JP2024529347A5 (https=)
KR102769567B1 (ko) 단백질 키나제 억제제로서의 벤조락탐 화합물
JP2022531932A5 (https=)
RU2630677C2 (ru) Соединения
KR101694383B1 (ko) 이미다조피롤리디논 화합물
JP2022528562A5 (https=)
JP2016523911A5 (https=)
JP2018530591A5 (https=)
JP2021500345A5 (https=)
JP2020527560A5 (https=)
RU2007128625A (ru) Гетероциклические замещенные фенилметаноны в качестве ингибиторов переносчика глицина 1
JP2020531498A5 (https=)
RU2010137300A (ru) Модуляторы бета-амилоида
JP2018520201A5 (https=)
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
JP2018507235A5 (https=)
JP2021535134A5 (https=)
JP2008156336A5 (https=)
JP2020526547A5 (https=)